Industry Research Reports
Home > Reports > Service & Software > Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-07-31
Pages: 147 Pages
Report ld: 4815975
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Adeno-Associated Virus (AAV) Packaging Service Market Size(US$)
CAGR 2025-2031
8.8%
Market Size,2031
USD 2,488
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,500 million
Market Forecast in 2031(Value)
US$ 2,488 million
CAGR
8.8%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1390 million in 2024 to US$ 2488 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Adeno-associated virus (AAV) is a type of parvovirus that has the ability to infect both dividing and non-dividing cells. It usually relies on co-infection with adenovirus or herpes virus to help it replicate and amplify in vivo. Recombinant adeno-associated virus (rAAV) vectors only need to carry the cis-element ITR to produce recombinant AAV particles. Due to the lack of Rep gene, the recombinant AAV viral genome does not integrate into the host genome and exists as an extrachromosomal free body for a long time. These characteristics make AAV viral vectors a gene delivery tool with great application prospects. Compared with other viral vectors, AAV has many advantages: 1) Strong diffusibility: rAAV is small in size and high in titer. Compared with adenovirus and lentivirus, it has higher diffusivity and can cross the blood-brain barrier, making it an ideal tool for infecting the nervous system; 2) High specificity: rAAV has multiple serotypes, and different serotypes have different recognition and infection abilities for different tissues. It is a tool virus preferred by animal experiments; 3) High safety: rAAV persists outside the chromosome, reducing the risk of mutation, and has low immunogenicity, so it can be directly used for human gene therapy.
From a downstream perspective, Gene Therapy accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Adeno-Associated Virus (AAV) Packaging Service leading manufacturers including Packgene, VectorBuilder, Ubigene, GenScript, Abace Biology, Genecfps, GENEWIZ, Obio Technology, Charles River Laboratories, Takara Bio, etc., dominate supply; the top five capture approximately % of global revenue, with Packgene leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Adeno-Associated Virus (AAV) Packaging Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Packgene
- VectorBuilder
- Ubigene
- GenScript
- Abace Biology
- Genecfps
- GENEWIZ
- Obio Technology
- Charles River Laboratories
- Takara Bio
- abm
- Cell Biolabs
- Cyagen
- Vector Biolabs
- Lonza
- Oxford BioMedica
- Catalent
- Wuxi Shengji Pharmaceuticals
- Boten Biotech
- Cytiva
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Small Scale
- Medium Scale
- Large Scale
Segment by Application
- Gene Therapy
- Scientific Research
CHAPTER OUTLINE
Chapter 1: Defines the Adeno-Associated Virus (AAV) Packaging Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report?
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Adeno-Associated Virus (AAV) Packaging Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Small Scale
1.2.3 Medium Scale
1.2.4 Large Scale
1.3 Market Segmentation by Application
1.3.1 Global Adeno-Associated Virus (AAV) Packaging Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Gene Therapy
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Adeno-Associated Virus (AAV) Packaging Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Adeno-Associated Virus (AAV) Packaging Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Adeno-Associated Virus (AAV) Packaging Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Small Scale Market Size by Players
3.3.2 Medium Scale Market Size by Players
3.3.3 Large Scale Market Size by Players
3.4 Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Adeno-Associated Virus (AAV) Packaging Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2020-2031)
6.4 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2020-2031)
7.4 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Adeno-Associated Virus (AAV) Packaging Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2020-2031)
9.4 Central and South America Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Adeno-Associated Virus (AAV) Packaging Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Packgene
11.1.1 Packgene Corporation Information
11.1.2 Packgene Business Overview
11.1.3 Packgene Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.1.4 Packgene Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.1.5 Packgene Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2024
11.1.6 Packgene Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2024
11.1.7 Packgene Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2024
11.1.8 Packgene Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
11.1.9 Packgene Recent Developments
11.2 VectorBuilder
11.2.1 VectorBuilder Corporation Information
11.2.2 VectorBuilder Business Overview
11.2.3 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.2.4 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.2.5 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2024
11.2.6 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2024
11.2.7 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2024
11.2.8 VectorBuilder Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
11.2.9 VectorBuilder Recent Developments
11.3 Ubigene
11.3.1 Ubigene Corporation Information
11.3.2 Ubigene Business Overview
11.3.3 Ubigene Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.3.4 Ubigene Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.3.5 Ubigene Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2024
11.3.6 Ubigene Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2024
11.3.7 Ubigene Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2024
11.3.8 Ubigene Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
11.3.9 Ubigene Recent Developments
11.4 GenScript
11.4.1 GenScript Corporation Information
11.4.2 GenScript Business Overview
11.4.3 GenScript Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.4.4 GenScript Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.4.5 GenScript Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2024
11.4.6 GenScript Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2024
11.4.7 GenScript Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2024
11.4.8 GenScript Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
11.4.9 GenScript Recent Developments
11.5 Abace Biology
11.5.1 Abace Biology Corporation Information
11.5.2 Abace Biology Business Overview
11.5.3 Abace Biology Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.5.4 Abace Biology Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.5.5 Abace Biology Adeno-Associated Virus (AAV) Packaging Service Revenue by Product in 2024
11.5.6 Abace Biology Adeno-Associated Virus (AAV) Packaging Service Revenue by Application in 2024
11.5.7 Abace Biology Adeno-Associated Virus (AAV) Packaging Service Revenue by Geographic Area in 2024
11.5.8 Abace Biology Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
11.5.9 Abace Biology Recent Developments
11.6 Genecfps
11.6.1 Genecfps Corporation Information
11.6.2 Genecfps Business Overview
11.6.3 Genecfps Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.6.4 Genecfps Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.6.5 Genecfps Recent Developments
11.7 GENEWIZ
11.7.1 GENEWIZ Corporation Information
11.7.2 GENEWIZ Business Overview
11.7.3 GENEWIZ Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.7.4 GENEWIZ Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.7.5 GENEWIZ Recent Developments
11.8 Obio Technology
11.8.1 Obio Technology Corporation Information
11.8.2 Obio Technology Business Overview
11.8.3 Obio Technology Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.8.4 Obio Technology Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.8.5 Obio Technology Recent Developments
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Corporation Information
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.9.4 Charles River Laboratories Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.9.5 Charles River Laboratories Recent Developments
11.10 Takara Bio
11.10.1 Takara Bio Corporation Information
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.10.4 Takara Bio Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 abm
11.11.1 abm Corporation Information
11.11.2 abm Business Overview
11.11.3 abm Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.11.4 abm Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.11.5 abm Recent Developments
11.12 Cell Biolabs
11.12.1 Cell Biolabs Corporation Information
11.12.2 Cell Biolabs Business Overview
11.12.3 Cell Biolabs Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.12.4 Cell Biolabs Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.12.5 Cell Biolabs Recent Developments
11.13 Cyagen
11.13.1 Cyagen Corporation Information
11.13.2 Cyagen Business Overview
11.13.3 Cyagen Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.13.4 Cyagen Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.13.5 Cyagen Recent Developments
11.14 Vector Biolabs
11.14.1 Vector Biolabs Corporation Information
11.14.2 Vector Biolabs Business Overview
11.14.3 Vector Biolabs Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.14.4 Vector Biolabs Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.14.5 Vector Biolabs Recent Developments
11.15 Lonza
11.15.1 Lonza Corporation Information
11.15.2 Lonza Business Overview
11.15.3 Lonza Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.15.4 Lonza Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.15.5 Lonza Recent Developments
11.16 Oxford BioMedica
11.16.1 Oxford BioMedica Corporation Information
11.16.2 Oxford BioMedica Business Overview
11.16.3 Oxford BioMedica Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.16.4 Oxford BioMedica Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.16.5 Oxford BioMedica Recent Developments
11.17 Catalent
11.17.1 Catalent Corporation Information
11.17.2 Catalent Business Overview
11.17.3 Catalent Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.17.4 Catalent Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.17.5 Catalent Recent Developments
11.18 Wuxi Shengji Pharmaceuticals
11.18.1 Wuxi Shengji Pharmaceuticals Corporation Information
11.18.2 Wuxi Shengji Pharmaceuticals Business Overview
11.18.3 Wuxi Shengji Pharmaceuticals Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.18.4 Wuxi Shengji Pharmaceuticals Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.18.5 Wuxi Shengji Pharmaceuticals Recent Developments
11.19 Boten Biotech
11.19.1 Boten Biotech Corporation Information
11.19.2 Boten Biotech Business Overview
11.19.3 Boten Biotech Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.19.4 Boten Biotech Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.19.5 Boten Biotech Recent Developments
11.20 Cytiva
11.20.1 Cytiva Corporation Information
11.20.2 Cytiva Business Overview
11.20.3 Cytiva Adeno-Associated Virus (AAV) Packaging Service Product Features and Attributes
11.20.4 Cytiva Adeno-Associated Virus (AAV) Packaging Service Revenue and Gross Margin (2020-2025)
11.20.5 Cytiva Recent Developments
12 Adeno-Associated Virus (AAV) Packaging ServiceIndustry Chain Analysis
12.1 Adeno-Associated Virus (AAV) Packaging Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Adeno-Associated Virus (AAV) Packaging Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Adeno-Associated Virus (AAV) Packaging Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Adeno-Associated Virus (AAV) Packaging Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus (AAV) Packaging Service as of 2024)
Table 11. Global Adeno-Associated Virus (AAV) Packaging Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Adeno-Associated Virus (AAV) Packaging Service Companies Headquarters
Table 13. Global Adeno-Associated Virus (AAV) Packaging Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Adeno-Associated Virus (AAV) Packaging Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Adeno-Associated Virus (AAV) Packaging Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Adeno-Associated Virus (AAV) Packaging Service Growth Accelerators and Market Barriers
Table 25. North America Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Adeno-Associated Virus (AAV) Packaging Service Growth Accelerators and Market Barriers
Table 27. Europe Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Adeno-Associated Virus (AAV) Packaging Service Investment Opportunities and Key Challenges
Table 31. Central and South America Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Packgene Corporation Information
Table 35. Packgene Description and Major Businesses
Table 36. Packgene Product Features and Attributes
Table 37. Packgene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Packgene Revenue Proportion by Product in 2024
Table 39. Packgene Revenue Proportion by Application in 2024
Table 40. Packgene Revenue Proportion by Geographic Area in 2024
Table 41. Packgene Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
Table 42. Packgene Recent Developments
Table 43. VectorBuilder Corporation Information
Table 44. VectorBuilder Description and Major Businesses
Table 45. VectorBuilder Product Features and Attributes
Table 46. VectorBuilder Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. VectorBuilder Revenue Proportion by Product in 2024
Table 48. VectorBuilder Revenue Proportion by Application in 2024
Table 49. VectorBuilder Revenue Proportion by Geographic Area in 2024
Table 50. VectorBuilder Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
Table 51. VectorBuilder Recent Developments
Table 52. Ubigene Corporation Information
Table 53. Ubigene Description and Major Businesses
Table 54. Ubigene Product Features and Attributes
Table 55. Ubigene Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Ubigene Revenue Proportion by Product in 2024
Table 57. Ubigene Revenue Proportion by Application in 2024
Table 58. Ubigene Revenue Proportion by Geographic Area in 2024
Table 59. Ubigene Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
Table 60. Ubigene Recent Developments
Table 61. GenScript Corporation Information
Table 62. GenScript Description and Major Businesses
Table 63. GenScript Product Features and Attributes
Table 64. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. GenScript Revenue Proportion by Product in 2024
Table 66. GenScript Revenue Proportion by Application in 2024
Table 67. GenScript Revenue Proportion by Geographic Area in 2024
Table 68. GenScript Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
Table 69. GenScript Recent Developments
Table 70. Abace Biology Corporation Information
Table 71. Abace Biology Description and Major Businesses
Table 72. Abace Biology Product Features and Attributes
Table 73. Abace Biology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Abace Biology Revenue Proportion by Product in 2024
Table 75. Abace Biology Revenue Proportion by Application in 2024
Table 76. Abace Biology Revenue Proportion by Geographic Area in 2024
Table 77. Abace Biology Adeno-Associated Virus (AAV) Packaging Service SWOT Analysis
Table 78. Abace Biology Recent Developments
Table 79. Genecfps Corporation Information
Table 80. Genecfps Description and Major Businesses
Table 81. Genecfps Product Features and Attributes
Table 82. Genecfps Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Genecfps Recent Developments
Table 84. GENEWIZ Corporation Information
Table 85. GENEWIZ Description and Major Businesses
Table 86. GENEWIZ Product Features and Attributes
Table 87. GENEWIZ Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. GENEWIZ Recent Developments
Table 89. Obio Technology Corporation Information
Table 90. Obio Technology Description and Major Businesses
Table 91. Obio Technology Product Features and Attributes
Table 92. Obio Technology Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Obio Technology Recent Developments
Table 94. Charles River Laboratories Corporation Information
Table 95. Charles River Laboratories Description and Major Businesses
Table 96. Charles River Laboratories Product Features and Attributes
Table 97. Charles River Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Charles River Laboratories Recent Developments
Table 99. Takara Bio Corporation Information
Table 100. Takara Bio Description and Major Businesses
Table 101. Takara Bio Product Features and Attributes
Table 102. Takara Bio Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Takara Bio Recent Developments
Table 104. abm Corporation Information
Table 105. abm Description and Major Businesses
Table 106. abm Product Features and Attributes
Table 107. abm Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. abm Recent Developments
Table 109. Cell Biolabs Corporation Information
Table 110. Cell Biolabs Description and Major Businesses
Table 111. Cell Biolabs Product Features and Attributes
Table 112. Cell Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Cell Biolabs Recent Developments
Table 114. Cyagen Corporation Information
Table 115. Cyagen Description and Major Businesses
Table 116. Cyagen Product Features and Attributes
Table 117. Cyagen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Cyagen Recent Developments
Table 119. Vector Biolabs Corporation Information
Table 120. Vector Biolabs Description and Major Businesses
Table 121. Vector Biolabs Product Features and Attributes
Table 122. Vector Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Vector Biolabs Recent Developments
Table 124. Lonza Corporation Information
Table 125. Lonza Description and Major Businesses
Table 126. Lonza Product Features and Attributes
Table 127. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. Lonza Recent Developments
Table 129. Oxford BioMedica Corporation Information
Table 130. Oxford BioMedica Description and Major Businesses
Table 131. Oxford BioMedica Product Features and Attributes
Table 132. Oxford BioMedica Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Oxford BioMedica Recent Developments
Table 134. Catalent Corporation Information
Table 135. Catalent Description and Major Businesses
Table 136. Catalent Product Features and Attributes
Table 137. Catalent Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. Catalent Recent Developments
Table 139. Wuxi Shengji Pharmaceuticals Corporation Information
Table 140. Wuxi Shengji Pharmaceuticals Description and Major Businesses
Table 141. Wuxi Shengji Pharmaceuticals Product Features and Attributes
Table 142. Wuxi Shengji Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
Table 143. Wuxi Shengji Pharmaceuticals Recent Developments
Table 144. Boten Biotech Corporation Information
Table 145. Boten Biotech Description and Major Businesses
Table 146. Boten Biotech Product Features and Attributes
Table 147. Boten Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 148. Boten Biotech Recent Developments
Table 149. Cytiva Corporation Information
Table 150. Cytiva Description and Major Businesses
Table 151. Cytiva Product Features and Attributes
Table 152. Cytiva Revenue (US$ Million) and Gross Margin (2020-2025)
Table 153. Cytiva Recent Developments
Table 154. Raw Materials Key Suppliers
Table 155. Distributors List
Table 156. Market Trends and Market Evolution
Table 157. Market Drivers and Opportunities
Table 158. Market Challenges, Risks, and Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Adeno-Associated Virus (AAV) Packaging Service Product Picture
Figure 2. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Small Scale Product Picture
Figure 4. Medium Scale Product Picture
Figure 5. Large Scale Product Picture
Figure 6. Global Adeno-Associated Virus (AAV) Packaging Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Gene Therapy
Figure 8. Scientific Research
Figure 9. Adeno-Associated Virus (AAV) Packaging Service Report Years Considered
Figure 10. Global Adeno-Associated Virus (AAV) Packaging Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 12. Global Adeno-Associated Virus (AAV) Packaging Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Region (2020-2031)
Figure 14. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Small Scale Revenue Market Share by Player in 2024
Figure 17. Medium Scale Revenue Market Share by Player in 2024
Figure 18. Large Scale Revenue Market Share by Player in 2024
Figure 19. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Type (2020-2031)
Figure 20. Global Adeno-Associated Virus (AAV) Packaging Service Revenue Market Share by Application (2020-2031)
Figure 21. North America Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (2020-2031) & (US$ Million)
Figure 22. North America Top 5 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2024
Figure 23. North America Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 24. North America Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2020-2031)
Figure 25. US Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 26. Canada Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 27. Mexico Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 28. Europe Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (2020-2031) & (US$ Million)
Figure 29. Europe Top 5 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2024
Figure 30. Europe Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Type (2020-2031)
Figure 31. Europe Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2020-2031)
Figure 32. Germany Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 33. France Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 34. U.K. Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 35. Italy Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 36. Russia Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Top 8 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2024
Figure 39. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Type (2020-2031)
Figure 40. Asia-Pacific Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2020-2031)
Figure 41. Indonesia Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 42. Japan Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 43. South Korea Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 44. Australia Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 45. India Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 46. Indonesia Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 47. Vietnam Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 48. Malaysia Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 49. Philippines Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 50. Singapore Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2031) & (US$ Million)
Figure 51. Central and South America Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Central and South America Top 5 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2024
Figure 53. Central and South America Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Type (2020-2031)
Figure 54. Central and South America Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2020-2031)
Figure 55. Brazil Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2025) & (US$ Million)
Figure 56. Argentina Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2025) & (US$ Million)
Figure 57. Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Revenue YoY (2020-2031) & (US$ Million)
Figure 58. Middle East and Africa Top 5 Players Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) in 2024
Figure 59. South America Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Type (2020-2031)
Figure 60. Middle East and Africa Adeno-Associated Virus (AAV) Packaging Service Revenue (US$ Million) by Application (2020-2031)
Figure 61. GCC Countries Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2025) & (US$ Million)
Figure 62. Israel Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2025) & (US$ Million)
Figure 63. Egypt Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2025) & (US$ Million)
Figure 64. South Africa Adeno-Associated Virus (AAV) Packaging Service Revenue (2020-2025) & (US$ Million)
Figure 65. Adeno-Associated Virus (AAV) Packaging Service Industry Chain Mapping
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 8.8% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Adeno-Associated Virus (AAV) Packaging Service market?
What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2031?
What is the annual compound growth rate of the global Adeno-Associated Virus (AAV) Packaging Service market size from 2025 to 2031?
What was the global market size of Adeno-Associated Virus (AAV) Packaging Service in 2025?
Related Reports
Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1249 million in 2025 to US$ 2627 million by 2032, at a CAGR of 11.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 161
USD 4900.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1249 million in 2025 and is forecast to reach a readjusted size of US$ 2627 million by 2032 with a CAGR of 11.1% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 149
USD 4250.00
(Single User License)
Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1249 million in 2025 and is projected to reach US$ 2627 million, growing at a CAGR of 11.1% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 153
USD 3950.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2026
The global Adeno-Associated Virus (AAV) Packaging Service market was valued at US$ 1249 million in 2025 and is anticipated to reach US$ 2627 million by 2032, at a CAGR of 11.1% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 144
USD 2900.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 107
USD 4250.00
(Single User License)
Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-03-12
Pages: 122
USD 3950.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2025
The global market for Adeno-Associated Virus (AAV) Packaging Service was valued at US$ 1390 million in the year 2024 and is projected to reach a revised size of US$ 2488 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published Date: 2025-03-12
Pages: 98
USD 2900.00
(Single User License)
Global and United States Adeno-Associated Virus (AAV) Packaging Service Market Report & Forecast 2024-2030
The global Adeno-Associated Virus (AAV) Packaging Service revenue was US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 125
USD 4350.00
(Single User License)
Adeno-Associated Virus (AAV) Packaging Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 125
USD 3950.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Insights, Forecast to 2030
Valued at US$ 1390 million in 2024, the global Adeno-Associated Virus (AAV) Packaging Service market is forecast to reach US$ 2305 million by 2030, at a CAGR of 8.8% during the forecast period.
Published Date: 2025-01-01
Pages: 159
USD 4900.00
(Single User License)
Global Adeno-Associated Virus (AAV) Packaging Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Adeno-Associated Virus (AAV) Packaging Service market is projected to grow from US$ 1249 million in 2025 to US$ 2627 million by 2032, at a CAGR of 11.1% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 161
USD 4900.00 (Single User License)Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1249 million in 2025 and is forecast to reach a readjusted size of US$ 2627 million by 2032 with a CAGR of 11.1% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 149
USD 4250.00 (Single User License)Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1249 million in 2025 and is projected to reach US$ 2627 million, growing at a CAGR of 11.1% from 2026 to 2032.
Published: 2026-07-18
Pages: 153
USD 3950.00 (Single User License)Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2026
The global Adeno-Associated Virus (AAV) Packaging Service market was valued at US$ 1249 million in 2025 and is anticipated to reach US$ 2627 million by 2032, at a CAGR of 11.1% from 2026 to 2032.
Published: 2026-07-18
Pages: 144
USD 2900.00 (Single User License)Global Adeno-Associated Virus (AAV) Packaging Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Adeno-Associated Virus (AAV) Packaging Service market size was US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 107
USD 4250.00 (Single User License)Adeno-Associated Virus (AAV) Packaging Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1390 million in 2024 and is forecast to a readjusted size of US$ 2488 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-03-12
Pages: 122
USD 3950.00 (Single User License)Global Adeno-Associated Virus (AAV) Packaging Service Market Research Report 2025
The global market for Adeno-Associated Virus (AAV) Packaging Service was valued at US$ 1390 million in the year 2024 and is projected to reach a revised size of US$ 2488 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published: 2025-03-12
Pages: 98
USD 2900.00 (Single User License)Global and United States Adeno-Associated Virus (AAV) Packaging Service Market Report & Forecast 2024-2030
The global Adeno-Associated Virus (AAV) Packaging Service revenue was US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published: 2025-01-01
Pages: 125
USD 4350.00 (Single User License)Adeno-Associated Virus (AAV) Packaging Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Adeno-Associated Virus (AAV) Packaging Service was estimated to be worth US$ 1282 million in 2023 and is forecast to a readjusted size of US$ 2305 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 125
USD 3950.00 (Single User License)Global Adeno-Associated Virus (AAV) Packaging Service Market Insights, Forecast to 2030
Valued at US$ 1390 million in 2024, the global Adeno-Associated Virus (AAV) Packaging Service market is forecast to reach US$ 2305 million by 2030, at a CAGR of 8.8% during the forecast period.
Published: 2025-01-01
Pages: 159
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
MARKET SEGMENTATION
Why This Report?
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now